Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Nath, Kavindra	University Of Pennsylvania United States	Metabolic Biomarkers of Response of Mantle Cell Lymphoma to Bruton Tyrosine Kinase Inhibition	5R01CA228457-05	Nicholas Hodges, Ph.D.
Nelson, Randy J.	West Virginia University United States	Mechanism Underlying Sleep Disruption by Mammary Tumors	5R21CA276027-02	Marjorie Perloff, M.D.
Neslund-Dudas, Christine Marie	Henry Ford Health + Michigan State University Health Sciences United States	HFH-MSU CSRN ACCrual Enrollment and Screening Site	3UG1CA287007-02S1	Elyse LeeVan, M.D., M.P.H.
Nguyen, Sang Minh	Vanderbilt University Medical Center United States	Gut Microbiome Profiles in Association with Breast Cancer Recurrence and Mortality	1R03CA292953-01	Gabriela Riscuta, M.D., CNS
Nicolson, Fay	Dana-Farber Cancer Inst United States	SESORRS endoscopy for the staging and evaluation of colorectal cancer	5R00CA266921-04
NINA, BHARDWAJ,	ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI United States	Immune determinants modulating cancer development in Lynch Syndrome	1UG3CA290517-01
Noble, Mark D	University Of Rochester United States	Prevention and treatment of paclitaxel-induced peripheral neuropathy	5R21CA277447-02	Rachel Altshuler, Ph.D.
Nolan, Michael Warren	North Carolina State University Raleigh United States	Evaluation of TRPM8-expressing neurons as novel regulators of acute radiotherapy-associated pain in patients with head and neck cancer	5R37CA248797-05	Asad Umar, D.V.M., Ph.D.
Nyamathi, Adeline M	University Of California-Irvine United States	Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India	3R01CA285063-03S2	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Oberg, Ann Laura	Mayo Clinic Rochester United States	Management and Data Coordination Unit for PCDC	5U24CA274496-04	Guillermo Marquez, Ph.D.
Ochoa, Augusto C.	Lsu Health Sciences Center United States	Gulf South Clinical Trials Network (Gulf South NCORP)	3UG1CA189854-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Olopade, Olufunmilayo F.	University Of Chicago United States	The Funding Mechanism of the Pilot Trial	5R01CA276652-03	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Ondrey, Frank G.	University Of Minnesota United States	Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia	5R01CA254270-04	Malgorzata Wojtowicz, M.D.
Onitilo, Adedayo A	Marshfield Clinic Research Foundation United States	Wisconsin NCI Community Oncology Research Program (WiNCORP)	3UG1CA189956-11S1	Vanessa A. White, M.P.H.
Osarogiagbon, Raymond U	Baptist Memorial Hospital - Tipton United States	Baptist Memorial Health Care/Mid South NCORP Consortium	3UG1CA189873-11S1	Brandy Heckman-Stoddard, Ph.D., M.P.H.